GO:0000164 protein phosphatase type 1 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000164 (protein phosphatase type 1 complex) is a cellular component defined as a magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) complex composed of a catalytic subunit plus one or more regulatory subunits that dictate substrate specificity, function and activity.
• The catalytic subunit PP1 (gene PPP1CA and paralogs) dephosphorylates serine/threonine residues and is targeted to distinct substrates by regulatory subunits such as PPP1R1A, PPP1R2, PPP1R3 family, PPP1R12A and PPP1R15A.
• PP1 complexes control diverse processes including insulin action and glycogen metabolism, cardiac calcium handling through phospholamban and RyR2, cell-cycle progression via the retinoblastoma protein, and smooth-muscle contraction through myosin phosphatase.
• Dysregulation of PP1 holoenzymes is linked to cancer cell-cycle defects, metabolic and cardiovascular disorders, and altered myosin phosphatase activity in smooth muscle.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of PP1 catalytic and regulatory subunit function in disease-relevant cell types.
• EDITGENE provides end-to-end CRISPR cell model generation and CRISPR library screening/bioinformatics to accelerate PP1 complex research.
Description
The protein phosphatase type 1 complex (GO:0000164) is a cellular component that carries magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity and consists of a catalytic subunit together with one or more regulatory subunits that dictate the phosphatase's substrate specificity, function and activity. This holoenzyme architecture allows a relatively small number of catalytic subunits to achieve remarkable substrate selectivity in distinct cellular contexts. PP1 complexes are central to reversible protein phosphorylation, a principal mechanism for controlling eukaryotic cell signaling, and they act on substrates ranging from metabolic enzymes to ion channels and cell-cycle regulators. Because PP1 activity is essential for normal physiology, researchers study its composition, assembly and regulation to understand diseases including cancer, metabolic disorders and cardiac dysfunction. The complex is also a paradigm for how regulatory subunits convert a broad-specificity enzyme into a precise molecular switch. This article summarizes the QuickGO definition, the biological processes and molecular mechanisms of PP1 complexes, the key genes involved, and the CRISPR-based methods used to interrogate them.
protein phosphatase type 1 complex At A Glance
| GO ID | GO:0000164 |
|---|---|
| GO term | protein phosphatase type 1 complex |
| Ontology | cellular_component |
| Synonym | none listed in QuickGO |
| Major function | Magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity; dephosphorylation of phosphoserine/phosphothreonine substrates |
| Complex composition | One catalytic subunit (PP1) plus one or more regulatory subunits that dictate substrate specificity, function and activity |
| Catalytic mechanism | Metal-dependent (magnesium) hydrolysis of phosphate from serine/threonine residues |
| Representative regulatory subunits | PPP1R1A, PPP1R2, PPP1R3 family, PPP1R12A, PPP1R15A |
| Associated processes | Insulin action and glycogen metabolism, cardiac calcium handling, cell-cycle control, smooth-muscle contraction |
What Is GO:0000164?
According to the Gene Ontology, GO:0000164 (protein phosphatase type 1 complex) is a protein complex that possesses magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity, and consists of a catalytic subunit and one or more regulatory subunits that dictates the phosphatase's substrate specificity, function, and activity. In other words, it is not a single protein but a modular holoenzyme: the catalytic subunit performs the dephosphorylation chemistry, while regulatory subunits act as targeting modules that bring the enzyme to specific substrates and modulate its activity.
Why Is protein phosphatase type 1 complex Important in Cell Biology?
The protein phosphatase type 1 complex is important because it is a principal effector of reversible protein phosphorylation, the dominant post-translational regulatory mechanism in eukaryotic cells. By pairing a conserved catalytic subunit with diverse regulatory subunits, PP1 holoenzymes achieve substrate specificity that is essential for processes as varied as insulin action and glycogen metabolism, cardiac calcium handling, cell-cycle progression and smooth-muscle contraction. Consequently, defects in PP1 complex composition or regulation contribute to human disease, and the complex is a major focus for both mechanistic studies and therapeutic target discovery.
• Controls reversible protein phosphorylation, a central signaling mechanism in eukaryotic cells.
• Regulates insulin action and glycogen metabolism through PP1 holoenzymes.
• Modulates cardiac calcium handling via phospholamban and the ryanodine receptor type 2.
• Participates in cell-cycle control through the retinoblastoma protein pathway.
• Regulates smooth-muscle contraction via myosin phosphatase.
• Provides a paradigm for how regulatory subunits dictate substrate specificity of a broad-specificity enzyme.
• Dysregulation is linked to cancer, metabolic disorders and cardiovascular disease.
• Offers druggable nodes for therapeutic intervention in phosphatase-driven pathologies.
• Serves as a model system for studying holoenzyme assembly and targeting.
• Enables CRISPR-based functional genomics of catalytic and regulatory subunits in disease models.
Core Biology of the protein phosphatase type 1 complex
Biological process: What Happens During protein phosphatase type 1 complex?
In simple terms: The PP1 complex removes phosphate groups from target proteins, reversing signals added by kinases.
The protein phosphatase type 1 complex catalyzes the dephosphorylation of phosphoserine and phosphothreonine residues on substrate proteins, thereby opposing kinase-mediated signaling. This reversible phosphorylation controls diverse biological processes, including insulin action and glycogen metabolism, cardiac calcium handling, cell-cycle progression and smooth-muscle contraction. The specificity of these events is determined by the regulatory subunits that assemble with the catalytic subunit.
Cellular component: Structure and Composition of protein phosphatase type 1 complex
In simple terms: The PP1 complex is built from a catalytic enzyme plus targeting subunits that tell it where to go.
The protein phosphatase type 1 complex consists of a catalytic subunit (PP1) and one or more regulatory subunits. The catalytic subunit contains the active site responsible for magnesium-dependent phosphatase activity, while regulatory subunits such as PPP1R1A, PPP1R2, PPP1R3 family members, PPP1R12A and PPP1R15A dictate substrate specificity, function and activity. This modular composition allows the same catalytic subunit to participate in distinct cellular processes depending on which regulatory subunit is bound.
Molecular function: Molecular Mechanism of protein phosphatase type 1 complex
In simple terms: The enzyme uses magnesium to help remove phosphate groups from proteins.
The catalytic mechanism of the protein phosphatase type 1 complex is magnesium-dependent serine/threonine phosphatase (AMD phosphatase) activity. The catalytic subunit hydrolyzes phosphate from phosphoserine/phosphothreonine substrates, and regulatory subunits modulate substrate recruitment and activity. This mechanism underlies PP1-dependent dephosphorylation events in insulin signaling, cardiac calcium regulation, cell-cycle control and smooth-muscle contraction.
Regulation of PP1 complex assembly and activity
In simple terms: Cells control PP1 by changing which regulatory subunits are present and how they are modified.
The activity and specificity of the protein phosphatase type 1 complex are regulated by the exchange of regulatory subunits and by post-translational modifications that alter holoenzyme assembly. For example, cAMP-dependent phosphorylation regulates a PP1/phospholamban complex in cardiac tissue, and activation of endogenous PP1 enhances the calcium sensitivity of the ryanodine receptor type 2 in cardiomyocytes. These regulatory events allow PP1 complexes to respond dynamically to cellular signals.
Physiological roles of PP1 complexes
In simple terms: PP1 complexes help control metabolism, heart function, cell division and muscle contraction.
PP1 complexes are required for normal insulin action and glycogen metabolism, cardiac calcium handling, cell-cycle progression through the retinoblastoma protein pathway, and smooth-muscle contraction via myosin phosphatase. These roles highlight the broad physiological importance of the complex and its relevance to human disease.
Key Genes Involved in GO:0000164 protein phosphatase type 1 complex
The following genes encode catalytic and regulatory subunits of the protein phosphatase type 1 complex, as well as key substrates and interacting proteins that define its biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPP1CA | Catalytic subunit of PP1 complex | Core phosphatase activity; knockout models for loss-of-function studies |
| PPP1CB | Catalytic subunit paralog | Tissue-specific PP1 functions; potential redundancy with PPP1CA |
| PPP1CC | Catalytic subunit paralog | Cell-cycle and metabolic roles; knockout models |
| PPP1R1A | Regulatory subunit (inhibitor-1) | Inhibits PP1; cAMP/PKA-regulated; metabolic and cardiac studies |
| PPP1R2 | Regulatory subunit (inhibitor-2) | Regulates PP1 activity and holoenzyme assembly |
| PPP1R3A | Glycogen-targeting regulatory subunit | Insulin action and glycogen metabolism |
| PPP1R3B | Glycogen-targeting regulatory subunit | Liver glycogen metabolism; metabolic disease models |
| PPP1R3C | Glycogen-targeting regulatory subunit | Muscle glycogen metabolism; insulin sensitivity |
| PPP1R12A | Myosin phosphatase regulatory subunit | Smooth-muscle contraction; myosin phosphatase |
| PPP1R15A | Stress-responsive regulatory subunit (GADD34) | Dephosphorylation of eIF2α; stress response studies |
| PPP1R15B | Constitutive eIF2α phosphatase regulatory subunit | Protein synthesis control; ER stress models |
| PLN | Phospholamban; PP1 substrate/regulator | Cardiac calcium handling; PP1/phospholamban complex |
| RYR2 | Ryanodine receptor type 2; PP1 substrate | Cardiac calcium release; PP1 modulation |
| RB1 | Retinoblastoma protein; PP1 substrate | Cell-cycle control; PP1/RB pathway |
| MYH11 | Smooth-muscle myosin heavy chain; PP1 substrate | Myosin phosphatase target |
| PPP1R14A | Myosin phosphatase inhibitor (CPI-17) | Smooth-muscle contraction regulation |
| PPP1R9A | Neurabin; PP1 regulatory subunit | Neuronal signaling; synaptic plasticity studies |
| PPP1R9B | Spinophilin; PP1 regulatory subunit | Neuronal and cytoskeletal regulation |
How Is protein phosphatase type 1 complex Regulated?
The protein phosphatase type 1 complex is regulated at multiple levels, including exchange of regulatory subunits, post-translational modifications of subunits, and subcellular targeting. cAMP-dependent phosphorylation regulates a PP1/phospholamban complex in cardiac tissue, and activation of endogenous PP1 enhances the calcium sensitivity of the ryanodine receptor type 2 in murine ventricular cardiomyocytes. These mechanisms allow PP1 complexes to respond to physiological signals and to integrate into diverse signaling networks.
protein phosphatase type 1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RB1 | Cell-cycle control and cancer | PP1 catalytic subunit knockout in cancer cell lines; RB1 phosphorylation assays |
| PPP1R3A | Insulin action and glycogen metabolism | Knockout or point-mutation models in muscle/liver cells; glycogen assays |
| PLN | Cardiac calcium handling | Knock-in or knockout in cardiomyocytes; PP1/phospholamban complex studies |
| RYR2 | Cardiac calcium release | Point-mutation knock-in in cardiomyocytes; calcium imaging |
| PPP1R12A | Smooth-muscle contraction | Knockout in smooth-muscle cells; myosin phosphatase activity assays |
Cancer and cell-cycle dysregulation
The protein phosphatase type 1 complex is linked to cell-cycle control through the retinoblastoma susceptibility gene product, RB1, which is a key PP1 substrate. Dysregulation of PP1-mediated dephosphorylation of RB1 can contribute to uncontrolled cell proliferation, making PP1 complexes relevant to cancer biology.
Metabolic disorders and insulin resistance
PP1 complexes regulate insulin action and glycogen metabolism. Alterations in PP1 holoenzyme composition or activity may contribute to insulin resistance and metabolic disease, providing a rationale for studying PP1 regulatory subunits in metabolic models.
Cardiac dysfunction and calcium handling
PP1 complexes modulate cardiac calcium handling through phospholamban and the ryanodine receptor type 2. Dysregulation of these PP1-dependent pathways can affect cardiac contractility and calcium signaling, linking the complex to heart disease.
Smooth-muscle and myosin phosphatase disorders
Myosin phosphatase, a PP1 complex containing PPP1R12A, regulates smooth-muscle contraction. Perturbations in this complex can affect vascular tone and smooth-muscle function, highlighting its role in cardiovascular and gastrointestinal disorders.
From protein phosphatase type 1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the loss-of-function phenotype of PP1 catalytic subunits? | CRISPR knockout of PPP1CA/PPP1CB/PPP1CC in disease-relevant cell lines |
| How do disease-associated point mutations affect PP1 complex activity? | CRISPR point-mutation knock-in of catalytic or regulatory subunit variants |
| How does a regulatory subunit dictate substrate specificity? | Knock-in of tagged regulatory subunits followed by interactome analysis |
| What is the effect of PP1 complex overexpression? | CRISPR-mediated overexpression of catalytic or regulatory subunits |
| Which genes modulate PP1 complex-dependent phenotypes? | CRISPR library screening with pathway-focused or genome-wide libraries |
| How does PP1 complex composition change in disease? | Patient-derived cells with CRISPR-engineered isogenic controls |
How to Study the protein phosphatase type 1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphatase activity assay | Magnesium-dependent serine/threonine phosphatase activity | Measuring PP1 complex catalytic function |
| Co-immunoprecipitation + mass spectrometry | Protein-protein interactions and holoenzyme composition | Identifying PP1 regulatory subunits and substrates |
| Phospho-specific Western blotting | Phosphorylation status of PP1 substrates | Monitoring PP1 activity on RB1, phospholamban, RyR2 |
| CRISPR knockout | Loss-of-function phenotype | Testing PP1 subunit requirement in disease models |
| CRISPR point-mutation knock-in | Effect of specific disease variants | Dissecting catalytic or regulatory subunit mutations |
| CRISPR-mediated overexpression | Gain-of-function effects | Studying PP1 complex subunit dosage |
| CRISPR library screening | Genome-wide or pathway-level modifiers | Identifying genes that regulate PP1-dependent phenotypes |
| Bioinformatics analysis | Pathway enrichment and network inference | Interpreting PP1 complex omics data |
Phosphatase activity assays
Protein phosphatase type 1 complex activity can be measured using magnesium-dependent serine/threonine phosphatase assays with phosphopeptide or phosphoprotein substrates. These assays are used to determine the catalytic contribution of PP1 subunits and the modulatory effects of regulatory subunits.
Co-immunoprecipitation and proteomics
Co-immunoprecipitation coupled with mass spectrometry can identify regulatory subunits and substrates of the protein phosphatase type 1 complex. This approach is useful for defining holoenzyme composition in different cell types and disease states.
Phosphorylation-specific antibodies and Western blotting
Phosphorylation-specific antibodies against PP1 substrates such as RB1, phospholamban and RyR2 can be used to monitor PP1 complex activity in cells and tissues. These methods are widely applied to study PP1-dependent signaling in cardiac and cancer models.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in and overexpression models enable causal interrogation of PP1 complex genes. Combined with CRISPR library screening and bioinformatics, these approaches can identify modifiers of PP1 complex-dependent phenotypes in disease-relevant cells.
How CRISPR Can Be Used to Study GO:0000164 protein phosphatase type 1 complex
Knockout
CRISPR knockout of PP1 catalytic subunits (PPP1CA, PPP1CB, PPP1CC) or regulatory subunits (e.g., PPP1R12A, PPP1R15A) can reveal loss-of-function phenotypes in processes such as insulin action, cell-cycle control and smooth-muscle contraction. Knockout models are essential for determining which subunits are required for specific PP1 complex functions.
Point Mutation
CRISPR point-mutation knock-in can introduce disease-associated or catalytically inactivating mutations into PP1 complex genes. These models allow researchers to separate catalytic activity from scaffolding functions and to test the impact of specific residues on phosphatase activity and substrate specificity.
Knock-in
Knock-in of epitope tags, fluorescent reporters or regulatory subunit variants enables visualization and biochemical isolation of PP1 complexes. Tagged knock-in models are particularly useful for co-immunoprecipitation and proteomic studies of holoenzyme composition.
Overexpression
CRISPR-mediated overexpression of PP1 catalytic or regulatory subunits can model gain-of-function states and test whether increased PP1 complex activity alters disease-relevant phenotypes. Overexpression models complement knockout studies by revealing dosage-sensitive effects.
How EDITGENE Supports protein phosphatase type 1 complex Research
Researchers studying protein phosphatase type 1 complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease phenotype. EDITGENE provides the CRISPR cell model and screening services required to move from correlation to causation in PP1 complex research.
Contact EDITGENE today to design your custom CRISPR model for protein phosphatase type 1 complex research.
Frequently Asked Questions About protein phosphatase type 1 complex
What is the protein phosphatase type 1 complex?
The protein phosphatase type 1 complex (GO:0000164) is a cellular component that possesses magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity and consists of a catalytic subunit plus one or more regulatory subunits that dictate substrate specificity, function and activity.
What genes are involved in the protein phosphatase type 1 complex?
Key genes include the catalytic subunits PPP1CA, PPP1CB and PPP1CC, and regulatory subunits such as PPP1R1A, PPP1R2, PPP1R3A, PPP1R3B, PPP1R3C, PPP1R12A, PPP1R15A and PPP1R15B.
What does the protein phosphatase type 1 complex do?
It dephosphorylates phosphoserine and phosphothreonine residues on substrate proteins, thereby regulating processes such as insulin action, glycogen metabolism, cardiac calcium handling, cell-cycle progression and smooth-muscle contraction.
How is the protein phosphatase type 1 complex regulated?
It is regulated by exchange of regulatory subunits and post-translational modifications; for example, cAMP-dependent phosphorylation regulates a PP1/phospholamban complex in cardiac tissue, and PP1 activation enhances ryanodine receptor type 2 calcium sensitivity in cardiomyocytes.
Which diseases are linked to the protein phosphatase type 1 complex?
It has been linked to cancer through RB1-dependent cell-cycle control, metabolic disorders through insulin action and glycogen metabolism, and cardiac dysfunction through phospholamban and RyR2 regulation.
What is the role of PP1 in cell-cycle control?
PP1 dephosphorylates the retinoblastoma protein (RB1), a key regulator of cell-cycle progression, linking the complex to cell-cycle control and cancer biology.
How does PP1 affect cardiac calcium handling?
PP1 complexes regulate phospholamban and the ryanodine receptor type 2, thereby modulating cardiac calcium handling and contractility.
What is myosin phosphatase and how does it relate to PP1?
Myosin phosphatase is a PP1 complex that regulates smooth-muscle contraction; it contains the catalytic subunit PP1 and regulatory subunits such as PPP1R12A.
How can CRISPR be used to study the protein phosphatase type 1 complex?
CRISPR knockout, point-mutation, knock-in and overexpression models can be used to test the causal roles of PP1 catalytic and regulatory subunits in disease-relevant cells.
What methods are used to measure PP1 complex activity?
Common methods include magnesium-dependent phosphatase activity assays, co-immunoprecipitation with mass spectrometry, and phospho-specific Western blotting of PP1 substrates.
Conclusion
The protein phosphatase type 1 complex (GO:0000164) is a modular holoenzyme that dephosphorylates serine/threonine substrates and controls diverse physiological processes, including insulin action, cardiac calcium handling, cell-cycle progression and smooth-muscle contraction. Its catalytic subunit and regulatory subunits together determine substrate specificity and activity, making the complex a central node in reversible phosphorylation networks. Dysregulation of PP1 complexes is implicated in cancer, metabolic disorders and cardiovascular disease, underscoring its importance as a research and therapeutic target. CRISPR-based cell models and functional genomics provide powerful tools to dissect PP1 complex biology and to identify new intervention points.
References
- 2. Ragolia L et al.. 1998. Protein phosphatase-1 and insulin action.. Mol Cell Biochem 182(1-2):49-58 PMID: 9609113
- 4. Vafiadaki E et al.. 2013. Identification of a protein phosphatase-1/phospholamban complex that is regulated by cAMP-dependent phosphorylation.. PLoS One 8(11):e80867 PMID: 24244723
- 5. Potenza DM et al.. 2020. Activation of endogenous protein phosphatase 1 enhances the calcium sensitivity of the ryanodine receptor type 2 in murine ventricular cardiomyocytes.. J Physiol 598(6):1131-1150 PMID: 31943206
- 7. Hartshorne DJ et al.. 1999. Interactions of protein phosphatase type 1, with a focus on myosin phosphatase.. Mol Cell Biochem 190(1-2):79-84 PMID: 10098973
- 8. Rubin E et al.. 1998. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control.. Front Biosci 3:D1209-19 PMID: 9835651
